Western University, Canada

uwo.ca

Total trials

222

Active

59

Phase 3

5

Total enrollment

28,026

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 10 of 10 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
semaglutide2
Botulinum Toxin Type A4
Denosumab 60 mg/ml1
fluticasone furoate(FF)/umeclidinium (UMEC)/vilanterol(VI) (100/62.5/25) mcg1
Redesca1
Fragmin1
Fecal microbial transplant1
Lipiodal1
Psilocybin1
Biologic Therapy1

Next readouts

  • 2025-02-01
  • 2025-07-01
  • 2025-09
  • 2025-12
  • 2026-02
  • 2026-03-30
  • 2027-03-30
  • 2027-09
  • 2029-05-01
  • 2030-10

Top conditions

  • Sedentary Lifestyle8
  • Health Behaviour Change5
  • Parkinson Disease4
  • Head and Neck Cancer4
  • Functional Movement Disorder4
  • Ketosis4
  • Overweight3
  • Cervical Dystonia3

Frequently asked questions about Western University, Canada

How many clinical trials does Western University, Canada have on ClinicalTrials.gov?
Western University, Canada is listed as the lead sponsor on 222 clinical trials in ClinicalTrials.gov, 59 of which are currently active (recruiting, enrolling, or ongoing).
How many of Western University, Canada's trials are in Phase 3?
5 of Western University, Canada's trials are in Phase 3, spread across 10 active drug programs.
What therapeutic areas does Western University, Canada focus on?
Western University, Canada's most-studied conditions on ClinicalTrials.gov are Sedentary Lifestyle, Health Behaviour Change, Parkinson Disease, Head and Neck Cancer, Functional Movement Disorder.
When are Western University, Canada's next clinical trial readouts?
Western University, Canada has 10 upcoming primary-completion readouts tracked here; the soonest is “Prolonged Hypercoagulability Following Major Liver Resection for Malignancy”, expected around 2025-02-01.